Impact of maintenance therapy with fluoropyrimidines in advanced esophageal-gastric adenocarcinoma: a retrospective study in Mexican population. [PDF]
Dip Borunda AK +6 more
europepmc +1 more source
PARG Governs a PARylation-Ubiquitination Toggle that Stabilizes RAD51AP1 to Drive Homologous Recombination-Mediated Chemoresistance. [PDF]
He H +24 more
europepmc +1 more source
Severe Hyperammonemic Encephalopathy Associated With Gastrointestinal Bleeding During Capecitabine and Oxaliplatin Chemotherapy in a Patient With Rectal Adenocarcinoma. [PDF]
Komatsu T, Agrawal VA.
europepmc +1 more source
Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive <i>DPYD</i> Pharmacogenetic Testing. [PDF]
Rodríguez-García M +8 more
europepmc +1 more source
A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas. [PDF]
Low JL +13 more
europepmc +1 more source
Uptake of DPYD and UGT1A1 testing in Italy and adherence to pharmacogenetic guidelines: A 5-year perspective from an EQA provider. [PDF]
Roncato R +8 more
europepmc +1 more source
Thymidine phospholyrase (TP) is an essential enzyme in activating 5’-deoxy-5-fluorocytidine (5’- DFUR) into 5-fluorouracil (5-FU) and for the conversion of 5-FU into 5-fluoro-2’-deoxyuridine.
MANOME, Yoshinobu +3 more
core
Colorectal Cancer Treatment During Pregnancy. [PDF]
Green KL, Hatch R.
europepmc +1 more source
A Strategic Implementation Framework for Integrating Pharmacogenomics (PGx) into Personalized Healthcare in Saudi Arabia. [PDF]
Alrubaie KR +6 more
europepmc +1 more source

